Building on 126 years of healthcare leadership, a deep research bench and a collaborative culture that nurtures young investigators, Baylor is shaping the next generation of scientific leaders. These leaders will not only provide exceptional patient care but also develop groundbreaking diagnostics, therapies and interventions that have the potential to attract commercial investment and bring innovative solutions to the market.
The Baylor College of Medicine Innovation Institute, led by Joe Petrosino, Ph.D., chief scientific innovation officer, partners with faculty to translate new discoveries and intellectual property (IP) to the commercial sector. The Innovation Institute manages Baylor’s IP through market evaluation, IP protection and strategic development, with the goal of finding the right path to market for each new discovery, including establishing commercial partnerships and launching new companies, as appropriate.